Surveillance ophtalmologique de la prise des antipaludéens de synthèse au long cours : mise au point et conduite à tenir à partir de 2003
Tóm tắt
Từ khóa
Tài liệu tham khảo
François J, De Rouck A, Cambie E, Zanen A. L’électro-diagnostic des affections rétiniennes. Rapport Soc Belge Ophtalmol Masson, Paris 1974, p. 348.
Furst, 1996, Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases, Lupus, 5, 11, 10.1177/096120339600500104
Thorne, 1999, Retinopathy after long term, standard doses of hydroxychloroquine, Br J Ophthalmol, 83, 1201, 10.1136/bjo.83.10.1194h
Shroyer, 2001, Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease?, Am J Ophthalmol, 131, 761, 10.1016/S0002-9394(01)00838-8
El-Sayed, 1998, Profiles of serum proteins and free amino acids associated with chloroquine retinopathy, Acta Ophthalmol Scand, 76, 422, 10.1034/j.1600-0420.1998.760407.x
Meyniel, 1992, Implication du PAF (Platelet-Activating factor) dans la rétinopathie à la chloroquine, CR Acad Sci III, 314, 61
Maenpaa, 2002, Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells, Pharmacol Toxicol, 91, 116, 10.1034/j.1600-0773.2002.910305.x
Toimela, 1998, Effects of tamoxifen, toremifene and chloroquine on the lysosomal enzymes in cultured retinal pigment epithelial cells, Pharmacol Toxicol, 83, 246, 10.1111/j.1600-0773.1998.tb01477.x
Ivana, 1989, A Study of the mechanisms of Choroquine retinopathy II Chloroquine Effect on Protein Synthesis of Retina, Ophthalmic Res, 21, 272, 10.1159/000266819
Rosenthal, 1978, Chloroquine retinopathy in the rhesus monkey, Invest Ophthalmol Vis Sci, 17, 1158
Browning, 2002, Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity, Am J Ophthalmol, 133, 649, 10.1016/S0002-9394(02)01392-2
Leid J. La vision des couleurs dans les maladies acquises de la rétine. In: Leid J. (coord.) Les Dyschromatopsies. Bull Soc Ophtalmol Fr, Rapport annuel 2001. Marseille : Imp. Lamy ; 2001 ; chap. 3-5 : pp. 229-32.
Hart, 1984, Static perimetry in chloroquine retinopathy Perifoveal patterns of visual field depression, Arch Ophthalmol, 102, 377, 10.1001/archopht.1984.01040030295022
Holder, 2001, Pattern electroretinography (PERG) and integrated approach to visual pathway diagnosis, Prog Ret Eye Res, 20, 531, 10.1016/S1350-9462(00)00030-6
So, 2003, Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography, Ophthalmic Surg Lasers Imaging, 34, 251, 10.3928/1542-8877-20030501-20
Kellner, 2000, Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction, Graefes Arch Clin Exp Ophthalmol, 238, 94, 10.1007/s004170050016
Marmor, 2002, Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology, Ophthalmology, 109, 1377, 10.1016/S0161-6420(02)01168-5
Labetoulle, 2003, Antipaludéens de synthèse : les conseils de l’American Academy of Ophthalmology relancent le débat, J Fr Ophtalmol, 26, 319